Search
Supernus Pharmaceuticals Inc
SUPNAdd to Watchlist
44.630USD
-0.980-2.15%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.59BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Net product sales-Qelbree
304.65M
42.37%
Net product sales - GOCOVRI
146.82M
20.42%
Collaboration revenue
53.00M
7.37%
Net product sales-APOKYN
47.77M
6.64%
Net product sales- Trokendi XR
42.42M
5.90%
Other
124.29M
17.29%
By RegionUSD
Name
Revenue
Proportion
United States
718.95M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Net product sales-Qelbree
304.65M
42.37%
Net product sales - GOCOVRI
146.82M
20.42%
Collaboration revenue
53.00M
7.37%
Net product sales-APOKYN
47.77M
6.64%
Net product sales- Trokendi XR
42.42M
5.90%
Other
124.29M
17.29%